In stark contrast to these promising results, efforts to suppress pathological CAF functions, by depleting α‐SMA‐positive fibroblasts or prevent stromal activation by targeting hedgehog signalling in multiple transgenic murine models of PDAC resulted in more aggressive, faster‐progressing metastatic disease [25, 26, 27]. The gene discussed is ACTA1; the disease is metastatic neoplasm.